STREAMLINE CARDIAC IMAGING WITH AI PRECISION

Radiological Society of North America’s Annual Meeting

Booth 3905

 

Join us at RSNA 2024


For the first time, Cleerly is excited to participate in the Radiological Society of North America’s Annual Meeting in Chicago, where we’ll be showcasing groundbreaking advancements in cardiac imaging. Join us as we demonstrate how Cleerly can aid workflow efficiency with CCTA analysis, rapid turnaround times, and seamless PACS integrations.

As leaders in AI-powered cardiac care, we’re proud to contribute to the future of radiology and highlight how our solutions can empower providers with precision and speed. Don’t miss the chance to connect one-on-one with our experts, explore live demos, and discuss how Cleerly can optimize your radiology workflow.

Fill out the form to book your meeting today!

RSNA 2024
McCormick Place, Chicago

 

 

Visit us at:

BOOTH 3905

 

 

Schedule Now

AHA-2023-meet-greet-food

 

Meet Cleerly Leadership

 

Monday, December 2nd 2:30 - 3:30 PM CT
Join us at Booth 3905 to meet Cleerly's Founder + CEO, Dr. James Min, and the rest of our incredible leadership team. Learn more about Cleerly's clinical validation and mission while enjoying a heart-healthy food offering!

Jim Min, MD, Founder and CEO, Cleerly

James K. Min, MD
Founder and CEO, Cleerly

Udo Hoffmann, MD, Chief Scientific Officer, Cleerly

Udo Hoffmann, MD
Chief Scientific Officer, Cleerly

James Earls, MD, Chief Medical Officer, Cleerly

James Earls, MD
Chief Medical Officer, Cleerly

Jim Hartman, Chief Revenue Officer, Cleerly

Jim Hartman
Chief Revenue Officer, Cleerly

 

Join Cleerly at These AHA Sessions and Events

 

Saturday, November 16
9:45 – 11:00 AM
New Discoveries in Microvasuclar Disease and Coronary Artery Disease: Sex and Age Differences

S103BC

Abstract Oral Presentation

Sex-Specific Coronary Plaque Characteristics and Risk of Cardiovascular Events: Insights from the ISCHEMIA Trial

10:45 - 10:55 AM

Suvasini Lakshmanan, MD, MS

9:45 – 11:00 AM
The Roads Less Travelled: Diverse Career Options in Cardiology

Membership Lounge (Science and Technology Hall, South Building, Level 3)

Panel Participant

There’s no one path in cardiology. Your interests, creativity, and innovative spirit will take you where you want. This session will expose you to the diverse nonclinical career paths in pharma, health technology, health policy and health administration to highlight just a few. How can you become a health tech innovator? How can you collaborate with industry? Hear from those who’ve paved the path.

James K. Min, MD, MSCCT

11:10 AM – 12:35 PM
New Concepts Regarding Vulnerable Plaque

Zone 4, Moderated Digital Poster 23

Moderated Digital Poster Session

Revascularization of patients with low-density non-calcified plaque was associated with lower occurrence of acute coronary syndrome

12:00 - 12:05 PM

Shant Malkaisan, MD

Sunday, November 17
3:15 – 4:15 PM
Sex Differences in CVD 2

Zone 3

Abstract Poster Session

Age- and Sex-Related Coronary Atherosclerosis by Artificial Intelligence Quantitative Coronary CT Angiography from the INVICTUS Registry

Ryo Okubo, PhD

Monday, November 18
9:30 – 10:45 AM
Coronary and Non-coronary Applications of Coronary CT and Photon Imaging

Zone 2, Moderated Digital Poster 8

Moderated Digital Poster Session

Distribution of Coronary Artery Plaque Volume by Artificial Intelligence Quantitative Coronary CT Angiography in general population: Results from the Miami Heart Study

10:20 - 10:25 AM

Keishi Ichikawa, MD, PhD

RSNA 2024 

McCormick Place, Chicago

 

 

Visit us at:

BOOTH 3905

 

Schedule Now
Patents

Cleerly continues to revolutionize heart attack and cardiovascular disease prevention and treatment everyday by inventing world-class technology. Cleerly invests significant time and resources in research and development towards this goal. To protect Cleerly’s research and development efforts, Cleerly has vigorously developed a robust intellectual property portfolio – all part of a strategy for protecting the innovations that make Cleerly an industry leader in cardiovascular disease prevention and treatment.

Cleerly’s products and services may be covered by or for use under one or more of U.S. Patent Nos. 11,922,627, 11,948,301, 12,023,190, 11,861,833, 11,967,078, 11,832,982, 11,690,586, 11,779,292, 11,730,437, 11,672,497, 11,737,718, 11,751,826, 11,660,058, 11,896,415, 11,751,830, 11,751,829, 11,302,001, 11,308,617, 11,238,587, 11,302,002, 11,321,840, 11,341,644, 11,244,451, 11,288,799, 11,276,170, 11,210,786, 11,232,564, 11,367,190, 11,315,247, 11,969,280, 11,094,060, 11,120,550, 11,120,549, 11,132,796, 11,094,061, 11,113,811, 11,501,436, 11,751,831, 11,642,092, 11,759,161, 11,317,883, 11,350,899, 11,766,230, 11,766,229, and 10,813,612, as well as other patents that are pending.

For additional information, please contact legal@cleerlyhealth.com.

Solutions
About

© 2024 Cleerly, Inc.